- Report
- April 2024
- 208 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- March 2024
- 168 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- March 2024
- 199 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- September 2023
- 180 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2021
- 245 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Report
- June 2021
- 213 Pages
Global
From €2654EUR$2,750USD£2,277GBP
€5309EUR$5,500USD£4,554GBP
- Report
- April 2018
- 80 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- May 2020
- 194 Pages
Global
From €1921EUR$1,990USD£1,648GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- January 2022
- 60 Pages
Global
From €3813EUR$3,950USD£3,270GBP
- Report
- August 2022
- 119 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- January 2018
- 618 Pages
Global
From €21234EUR$22,000USD£18,215GBP
- Report
- January 2021
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- August 2022
United States
From €1872EUR$1,940USD£1,606GBP
- Report
- August 2022
Global
From €1052EUR$1,090USD£902GBP
- Report
- February 2021
Global
From €2857EUR$2,960USD£2,451GBP
- Report
- July 2021
- 52 Pages
Global
From €3373EUR$3,495USD£2,894GBP
The Hepatitis C Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat the Hepatitis C virus, a contagious virus that can cause liver damage. These drugs are typically administered orally or intravenously and can be used to treat both acute and chronic infections. The drugs are designed to reduce the amount of virus in the body, reduce the risk of liver damage, and improve the quality of life for those infected.
The Hepatitis C Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, and Janssen Pharmaceuticals. Other companies, such as Mylan, Cipla, and Natco Pharma, also offer treatments for the virus. Show Less Read more